Barbara Kalsdorf
Overview
Explore the profile of Barbara Kalsdorf including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
48
Citations
840
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Reimann M, Avsar K, DiNardo A, Goldmann T, Gunther G, Hoelscher M, et al.
Pathog Immun
. 2025 Feb;
10(1):120-139.
PMID: 39911144
Rationale: Treatment monitoring of tuberculosis patients is complicated by a slow growth rate of . Recently, host RNA signatures have been used to monitor the response to tuberculosis treatment. Objective:...
2.
Neumann M, Reimann M, Chesov D, Popa C, Dragomir A, Popescu O, et al.
J Infect
. 2024 Dec;
90(2):106399.
PMID: 39733827
Objectives: Early detection of treatment failure is essential to improve the management of drug-resistant tuberculosis (DR-TB). We evaluated the molecular bacterial load assay (MBLA) in comparison to standard diagnostic tests...
3.
Eggeling J, Kalsdorf B, Schaub D, Schierholz S, Hammerl P, Nowak D, et al.
Pneumologie
. 2024 May;
79(1):87-91.
PMID: 38782000
A 43-year-old quarry worker, after being exposed to fine quartz dust for 16 years in a German quarry, is on the waiting list for a lung transplant. The inhalation of...
4.
Kohler N, Karakose H, Grobbel H, Hillemann D, Andres S, Konig C, et al.
Pharmaceutics
. 2023 Nov;
15(11).
PMID: 38004523
The treatment of drug-resistant relies on complex antibiotic therapy. Inadequate antibiotic exposure can lead to treatment failure, acquired drug resistance, and an increased risk of adverse events. Therapeutic drug monitoring...
5.
Brehm T, Kohler N, Schmiedel S, Terhalle E, Martensen J, Kalsdorf B, et al.
Inn Med (Heidelb)
. 2023 Jun;
64(7):701-707.
PMID: 37316702
Never before have so many people around the world been simultaneously affected by tuberculosis. Tuberculosis is the leading cause of death from a bacterial infectious disease worldwide. The World Health...
6.
Jafari C, Olaru I, Daduna F, Lange C, Kalsdorf B
Pathog Immun
. 2023 May;
7(2):189-202.
PMID: 37207169
Introduction: The rapid diagnosis of tuberculosis recurrence can be challenging due to persistently positive detection of -specific DNA from sputum and bronchopulmonary samples in the absence of active disease. Methods:...
7.
Maier C, Chesov D, Schaub D, Kalsdorf B, Andres S, Friesen I, et al.
Clin Microbiol Infect
. 2023 Feb;
29(6):751-757.
PMID: 36842637
Objectives: To describe long-term treatment outcomes in patients with multi-drug-resistant/rifampicin-resistant tuberculosis (MDR/RR-TB) and validate established outcome definitions for MDR/RR-TB treatment. Methods: Among patients with MDR/RR-TB admitted to a German MDR/RR-TB...
8.
Koehler N, Andres S, Merker M, Dreyer V, John A, Kuhns M, et al.
J Infect
. 2023 Feb;
86(5):520-524.
PMID: 36738862
No abstract available.
9.
Sibandze D, Kay A, Dreyer V, Sikhondze W, Dlamini Q, DiNardo A, et al.
Genome Med
. 2022 Sep;
14(1):107.
PMID: 36127736
No abstract available.
10.
Brandenburg J, Heyckendorf J, Marwitz F, Zehethofer N, Linnemann L, Gisch N, et al.
ACS Infect Dis
. 2022 Jun;
8(7):1303-1315.
PMID: 35763439
One-fourth of the global human population is estimated to be infected with strains of the complex (MTBC), the causative agent of tuberculosis (TB). Using lipidomic approaches, we show that tuberculostearic...